Abstract
Objective: The object is to study acacia catechu gum in situ, forming gels with prolonged retention times for ocular drug delivery.
Methods: This study was sample collection and extraction, pre-formulation research, drug melting point and solubility preparation of standard stock solution, lambda max determination, and preparation of ciprofloxacin hydrochloride in situ gel.
Results: The melting point of ciprofloxacin hydrochloride was found to be 290°C. The solubility of ciprofloxacin hydrochloride in pH 2.0 and pH 6.8 media is 7.88 0.005 mg/ml and 0.080 0.05 mg/ml. The max of ciprofloxacin hydrochloride was found to be 276–277 nm in simulated tear fluid pH 7.4. Prepared in situ gelling systems were evaluated for interaction studies to ensure that no interaction occurred between drugs and polymers. The pH of the formulations was found to be 7.1–7.4, and the drug content was in the range of 92–98%. All the prepared in situ gelling systems were evaluated for sterility. After 7 days of incubation, the results showed no microbial growth in all formulations.
Conclusion: The developed formulation is a viable alternative to the conventional eye drops by virtue of its ability to enhanced bioavailability through its longer precorneal residence time.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference40 articles.
1. Rajeshwari NP, Rachana SK. In situ gelling system: A novel approach for ophthalmic drug delivery. World J Pharm Pharm Sci 2014;3:423-40.
2. Sultana Y, Jain R, Aqil M, Ali A. Review of ocular drug delivery. Curr Drug Deliv 2006;3:207-17. doi: 10.2174/156720106776359186, PMID 16611007.
3. Furrer P, Delie F, Plazonnet B. Ophthalmic Drug Delivery, Modified- Release Drug Delivery Technology. Raleigh, NC: Pharmaceu Tech, Inc.; 2008. p. 59-84.
4. Remington JP. Remington: The Science and Practice of Pharmacy. Philadelphia, PA: Lippincott Williams and Wilkins; 2006.
5. Le Bourlais CA, Treupel-Acar L, Rhodes CT, Sado PA, Leverge R. New ophthalmic drug delivery systems. Drug Dev Ind Pharm 1995;21:19- 59. doi: 10.3109/03639049509048095.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献